On 1 April 2013 the National Institute for Biological Standards and Control (NIBSC), currently part of the Health Protection Agency (HPA), will officially become a new 'centre' of the Medicines and Healthcare products Regulatory Agency (MHRA) alongside the Clinical Practice Research Datalink (CPRD).
MHRA and NIBSC already work closely together and have common interests in managing risks associated with biological medicines, facilitating development of new medicines safely and effectively, and maintaining UK expertise and ability to contribute to assuring the quality and safety of medicines in Europe and beyond.
The developments will create a new organisation that is a world leader in supporting science and research and the regulation of medicines and medical devices, and will strengthen the support provided to the UK’s medicine’s industry.
NIBSC: National Institute for Biological Standards and Control 英国国家生物制品检定所
MHRA: Medicines and Healthcare products Regulatory Agency 英国药品和健康产品监管局
